+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ISHITADR ISHITADR

Ishita Drugs & Industries Share Price

₹73.75 -0.25 (-0.34%)

11 Sep, 2026 2:01 PM (IST)

Ishita Drugs & Industries live price: ₹73.75. It opened at ₹74 vs previous close ₹74; intraday high/low: ₹74/₹74. The 50 & 200 DMA stand at ₹74.10/₹75.20.

Ishita Drugs & Industries Performance

  • Today's Low
  • ₹74
  • Today's High
  • ₹74
  • 52 Week Low
  • ₹66
  • 52 Week High
  • ₹91
  • Open Price₹74
  • Previous Close₹74
  • Volume7
  • 50 DMA₹74.10
  • 100 DMA₹74.70
  • 200 DMA₹75.20

Ishita Drugs & Industries Chart

Investment Returns

  • Over 1 Month + 2.01%
  • Over 3 Month -7.23%
  • Over 6 Month -8.33%
  • Over 1 Year + 0.07%

Smart Investing Starts Here Start SIP with Ishita Drugs & Industries for Steady Growth!

Invest Now

Ishita Drugs & Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.2
  • PEG Ratio
  • -1
  • Market Cap Cr
  • 22
  • P/B Ratio
  • 1.9
  • Average True Range
  • 2.4
  • EPS
  • 2.4
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.2
  • RSI
  • 51.05
  • MFI
  • 91.38

Latest Stock News Updates

Ishita Drugs & Industries Ltd - 524400 - Weblink Intimation Letter To The Shareholders

Company has issued letters providing a weblink of Company''s website to access Annual report for Financial Year 2025-26 to those members who have not registered their email addresses.

Ishita Drugs & Industries Ltd - 524400 - Reg. 34 (1) Annual Report.

Annual Report for the Financial Year 2025-26 including Notice of 33rd Annual General Meeting of the Company to be held on 30.09.2026.

Ishita Drugs & Industries Ltd - 524400 - NOTICE OF 33RD ANNUAL GENERAL MEETING (AGM) ALONG WITH THE E-VOTING PERIOD

Notice of 33RD AGM of the Company which will be held on wednesday, 30th September, 2026 and E voting period for AGM commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (5:00 p.m. IST)

Ishita Drugs & Industries Financials

Ishita Drugs & Industries Technicals

EMA & SMA

Current Price
₹73.75
-0.25 (-0.34%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹73.50
  • 50 Day
  • ₹74.10
  • 100 Day
  • ₹74.70
  • 200 Day
  • ₹75.20

Resistance and Support

73.82 Pivot Speed
  • R3 74.00
  • R2 74.00
  • R1 74.00
  • S1 74.00
  • S2 74.00
  • S3 74.00

Ishita Drugs & Industries Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-08 Quarterly Results
2026-05-30 Audited Results
2026-02-07 Quarterly Results
2025-11-11 Quarterly Results
2025-08-12 Quarterly Results

Ishita Drugs & Industries Shareholding Pattern

50.04%
49.96%
0%

About Ishita Drugs & Industries

Ishita Drugs & Industries is engaged in the business of manufacturing of various APIs (Active Pharma Ingredients) and drug intermediates. It has built up a reputation as a manufacturer of “high quality” products and is known for its ethical dealings in business. The company supplies its products to leading pharmaceutical companies of India. The products are also being exported to various countries across the world. View More
  • NSE Symbol
  • ISHITADR
  • BSE Symbol
  • 524400
  • ISIN
  • INE806D01016

Similar Stocks to Ishita Drugs & Industries

Ishita Drugs & Industries FAQs

Ishita Drugs & Industries share price is ₹73 As on 11 September, 2026 | 13:58

The Market Cap of Ishita Drugs & Industries is ₹22.1 Cr As on 11 September, 2026 | 13:58

The P/E ratio of Ishita Drugs & Industries is 31.2 As on 11 September, 2026 | 13:58

The PB ratio of Ishita Drugs & Industries is 1.9 As on 11 September, 2026 | 13:58

The 52 week High & Low of Ishita Drugs & Industries is ₹90.8/₹66 respectively As on 11 September, 2026 | 13:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23